Why this status
- 17 Nov 2020: Trial started, NCT04834115
- 6 Apr 2021: Trial registered, NCT04834115
The trials
NCT04834115: Efficacy of Ivermectin in Outpatients With Non-severe COVID-19
- State
- State not given
- Phase
- Phase 3
- People
- 400 planned
- Started
- 17 Nov 2020
- Primary completion
- 30 Apr 2021
- Arms
- Ivermectin
- Results
- None posted
- 17 Nov 2020: Trial started
- 6 Apr 2021: Trial registered
How the status changed
- 19 Nov 2026: First set: Phase 3 trial
About the treatment
Kind of treatment: Drug.
Also known as Acarexx, Bimectin, Bovinet, Cardomec, CARDOTEK 30, Cevamec, Equimec, Eqvalan, Heartgard, Hyvermectin, Ivectin, IVERMECTIN (IVER P®) arm will receive IVM 600 µg / kg once daily plus standard care. CONTROL arm will receive standard care., Ivertin, Ivomec, Ivosint, Ivermectin (IVM), Ivermectin 0.4mg/kg/day for 5 days, Ivermectin 3 MG, Ivermectin 3mg Tab, Ivermectin Injectable Product, Ivermectin Oral Product, Ivermectin Pill, Ivermectin Tablets, Ivermectin Topical, Ivermectin nasal, Ivermectin oral, Jetamec, Mectizan, Noramectin, Noromectin, Oramec, Pandex, Phoenectin, Sklice, Soolantra, Stromectol, Uvemec, Vermic, Vetmec, Zimecterin, intranasal ivermectin spray.
Registries searched: ClinicalTrials.gov, through 17 Nov 2026.